KPV (Lysine–Proline–Valine) is a short synthetic tripeptide derived from the C-terminal region of α-MSH (alpha-melanocyte-stimulating hormone). It has been widely researched for its anti-inflammatory, immunomodulatory, and barrier-protective effects in both systemic and local inflammation models.
Each vial contains 10mg of high-purity lyophilized KPV, suitable for reconstitution under sterile laboratory conditions.
Key Research Areas:
-
Suppression of pro-inflammatory cytokines (e.g., IL-6, TNF-α, IL-1β)
-
NF-κB pathway inhibition
-
Gut barrier integrity and IBD model protection
-
Skin inflammation models (e.g., dermatitis, acne, psoriasis)
-
Immune modulation in chronic inflammation studies
Note: For research use only. Not intended for human or veterinary use.

There are no reviews yet.